Humana Medicare Advantage 2027 Cuts: 600,000 Members Must Shop

Humana's 2027 Medicare Advantage Cuts: What Shoppers Actually Need to Review

For the second year running, Humana is shrinking its Medicare Advantage footprint — and this time the scale is the largest of any carrier. The insurer has told investors that plans covering roughly 600,000 members will not be offered in 2027, which works out to about 8% of its 7.2 million Medicare Advantage members and the biggest single-carrier reduction announced for the plan year131516. The move follows a similar pullback during the 2025 cycle, when about 500,000 members were dropped from Humana's rolls7. For shoppers heading into this fall's Annual Enrollment, the practical question is no longer whether Humana is changing — it is what those changes mean for premiums, benefits, drug costs and the decision of whether to stay with the carrier at all.

Why Humana Is Cutting

The driver is financial. Humana President and CEO Jim Rechtin said in April that the gap between CMS funding and the cost of care has grown wider heading into the 2027 bid cycle, even though the Centers for Medicare and Medicaid Services finalized a 2.48% average payment increase for 2027117. Rechtin has framed the 2027 bids around returning the Medicare Advantage business to a sustainable margin of at least 3% by 2028, with progress expected next year16.

The specifics of the pullback are targeted rather than uniform. Chief Financial Officer Celeste Mellet told analysts on the July 29 second-quarter call that the exits concentrate on what she described as low-performing plans and markets, rather than trimming benefits evenly across the book of business7. The plans being dropped are mostly those rated 3.5 stars or below, contracts whose quality scores have slipped and, with them, the bonus payments that fund extra benefits1218. After the changes take effect, Humana's Medicare Advantage footprint will still cover 46 states and roughly 85% of U.S. counties12.

Humana had been a holdout on benefit cuts while rivals retrenched earlier, but that changed when executives concluded the payment rate was insufficient to cover rising medical costs28. Reuters reported in May that the reductions would fall on supplemental perks — dental, vision, hearing and fitness programs — and quoted one investment manager predicting all insurers would cut back but that Humana would cut the most18. Analysts expect similar moves from UnitedHealthcare and Aetna, though Medicare Advantage represents a much larger share of Humana's revenue — about 80%, versus 33% for Aetna and 12% for UnitedHealthcare — which explains why the pressure hits Humana hardest8.

The company expects to recapture a meaningful share of the displaced members: Mellet said Humana anticipates keeping roughly the same share it retained after the 2025 cuts, when just over 40% of affected enrollees moved into other Humana plans7.

What Is Not Happening

It is worth separating what is changing from what is not. Nobody affected is losing Medicare itself. A non-renewal means one private plan ends; federal Part A and Part B eligibility is untouched1420. Nor is Humana exiting the Medicare Advantage business — roughly 92% of its members are unaffected by the announced exits, and the company will continue selling plans across most of the country1519.

There is also a benefits story that cuts the other way. Some 2027 Humana plans reportedly add affordability features, including a Part B giveback that rebates a portion of the Part B premium through the Social Security check, no-cost in-network primary care visits in certain plans such as the USAA Honor Giveback options, and $0 copays for mental health services11. So the 2027 picture is not a pure subtraction: Humana is sharpening benefits in plans it wants to keep while eliminating the contracts that lose money.

The Timeline That Matters

The operative dates are concrete. Non-renewal letters went out in September 2026, and federally required notices are dated October 2; anyone whose plan is ending should have that letter in hand or arriving imminently1216. Coverage under discontinued plans ends December 31, 2026. Standard Annual Enrollment runs through December 7, but members affected by a non-renewal get a Special Enrollment Period that extends from December 8 through the end of February — a critical cushion for anyone who misses the main window14.

The letters are worth saving rather than discarding. They contain the plan details and the protections attached to the exit, and October 1 plan data will provide the first reliable confirmation of which specific plans are affected, since Humana disclosed a member count to investors but has not published a plan-by-plan or county-by-county list1315.

Drug Costs: The 2027 Part D Numbers

The prescription drug side brings its own shifts for 2027, and they are a mixed bag for beneficiaries. The annual out-of-pocket cap on covered drugs rises from $2,100 to $2,400 — a higher ceiling, but one that, once reached, makes covered medications free for the rest of the year2122. The maximum deductible rises from $615 to $700, and a temporary federal program that had been holding standalone drug plan premiums down expires after 2026, which could push Part D premiums upward21.

Some protections hold steady: insulin stays capped at $35 per month per covered product, recommended adult vaccines remain free with no deductible applied, and the "donut hole" coverage gap stays eliminated2122. On the policy front, 15 additional drugs gain negotiated Medicare pricing on top of the 10 whose negotiated prices took effect in 2026, extending the government's drug-price negotiation program into its second year22. For Humana shoppers, the practical step is checking how each candidate plan's formulary and tier structure interacts with their specific medications, because a plan's total cost depends far more on drug coverage than on the headline premium.

The Medicaid Connection

The broader fiscal squeeze shapes more than the Medicare line. Humana's own regulatory comments note that it provides comprehensive medical coverage for Medicaid beneficiaries in seven states, and the company has pressed CMS to fund Medicare Advantage at levels that fully reflect the cost of care3. Humana also warned CMS that its 2027 Advance Notice offset nearly all of a congressional physician-payment increase with a negative adjustment, effectively neutralizing the funding boost Congress enacted3. For dual-eligible beneficiaries — those enrolled in both Medicare and Medicaid — plan exits are more disruptive, since the coordinated-care model Humana describes as a safety net is exactly what disappears when a contract ends. Shoppers who rely on Medicaid alongside Medicare should verify that any replacement plan accommodates their dual coverage.

What Shoppers Should Do

The consensus across coverage of this story is that the real risk is inaction. The members who get hurt are the ones who set the non-renewal letter aside rather than acting on it15. Concretely, shoppers should:

• Confirm their plan's status. Non-renewal notices, or the October 1 plan data, are the only reliable answer; Humana has not published a county-level list1315.
• Review the Annual Notice of Change carefully. Even members whose plans survive may see changed premiums, copays, benefits or provider networks19.
• Watch for benefit reductions in supplemental perks. Dental, vision, hearing and fitness benefits are the likeliest targets across carriers, and chronic-condition management support may thin as well16.
• Check drug coverage against actual prescriptions. The rising $2,400 cap and $700 deductible make formulary and tier comparisons more consequential, and Part D premiums may rise as the federal premium-support program lapses21.
• Know the Medigap escape hatch. A qualifying plan non-renewal can trigger guaranteed-issue rights to a Medicare Supplement policy, barring insurers from rejecting applicants or charging more for pre-existing conditions — a protection grounded in federal rule, not carrier goodwill141620.

The Reading

Where the coverage converges is on scale and cause: roughly 600,000 members affected, targeted exits of low-performing, low-star contracts, and a funding gap between CMS payment and medical-cost trend71213. Where it diverges is emphasis — some coverage stresses the benefit enhancements arriving in retained plans11, while others stress that the whole market is under pressure and that Medigap holders, too, may see premium increases and fewer carrier options this cycle10.

The most defensible reading is that Humana is executing a deliberate margin-repair strategy: exit the contracts that lose money, sweeten the ones worth keeping, and aim for a 3% margin by 202817. That is rational corporate behavior, but it transfers shopping burden to consumers. Roughly 600,000 people must actively choose a new plan this fall, and history suggests fewer than half will stay with Humana by choice7. The takeaway for anyone on a Humana plan — affected or not — is that this is a year to read the mail, compare total costs rather than premiums, and treat the extended enrollment window not as a technicality but as a deadline with a safety net.